MSS Locally Advanced Rectal Adenocarcinoma Active Not Recruiting Phase 2 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0145714 (MSS Locally Advanced Rectal Adenocarcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05216653Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma (PRECAM)Treatment